β- Ga 2 O 3 single crystals were grown by the floating zone method and their conductivity along the b axis was controlled from <10−9 to 38 Ω−1 cm−1 by changing the growth atmosphere. By using feed rods doped with Sn, the grown crystal became highly conductive even under oxidative atmosphere. The optical transmission spectra showed that the β-Ga2O3 single crystal with 0.32 mm was transparent in the visible and ultraviolet region, with 20% transmittance at the fourth-harmonic wave of the Nd:YAG laser (266 nm). The band-gap widening was observed with the increasing of the carrier concentration. It is expected that the light of the KrF laser can be transmitted in the heavily doped β-Ga2O3.

Anisotropy of electrical and optical properties in β-Ga2O3 single crystals has been investigated at room temperature. The conductivity and mobility of the degenerate sample along the direction of b and c axes are 38 Ω−1 cm−1, 46 cm2 V−1 s−1, and 2.2 Ω−1 cm−1, 2.6 cm2 V−1 s−1, respectively. The absorption edges of the insulating sample for light polarized E//b and E//c were 4.79 and 4.52 eV, respectively. The rate of the band gap widening with increasing carrier concentration was much larger for E//b than E//c. The origin of these properties are discussed by considering the crystal and electronic structure of β-Ga2O3.

Akt/PKB is a serine/threonine kinase that plays an important role in survival when cells are exposed to different apoptotic stimuli. Aberrant activation of Akt/PKB in breast carcinoma is associated with poor prognosis and resistance to endocrine therapy and chemotherapy. The Akt signaling pathway currently attracts considerable attention as a new target for effective therapeutic strategies. We therefore investigated the relationship between activation of Akt and clinicopathologic variables including hormone receptor and HER2/neu status. Breast cancer tissues obtained from 252 patients were utilized for this study. We evaluated Akt activation by immunohistochemical assessment of the expression of phosphorylated Akt (pAkt) at Ser-473. Eighty-four cases (33.3%) were diagnosed as positive for pAkt expression. pAkt was significantly associated with HER2/neu overexpression (p < 0.0001). There was an inverse correlation between pAkt and PR expression (p 5 0.0321); however, there was no association between pAkt and ER expression. Survival analysis showed that pAkt positivity was associated with poor disease-free survival in cases with postoperative hormone therapy; however, there was no association in cases without hormone therapy. Our results indicate that Akt activation induced poor prognosis in patients who received adjuvant hormone therapy. This finding suggests that inhibition of the Akt signaling pathway may increase the efficacy of hormone therapy and improve the prognosis of patients who receive adjuvant hormone therapy. ' 2005 Wiley-Liss, Inc.

Growth factor receptor-mediated signal transduction has been implicated in conferring resistance to conventional chemotherapy on cancer cells. We describe a pathway that involves AKT/PI3K to mediate chemoresistance in gastric cancer patients. Primary gastric carcinoma tissues and corresponding normal mucosa were obtained from 76 gastric cancer patients who underwent surgery in the Department of Surgery II in Kyushu University Hospital from the years 1996-2000. AKT activation was investigated by immunostaining with a phosphorylation-specific antibody, and LOH (loss of heterozygosity) of PTEN was studied in the same samples. AKT was phosphorylated in 22 cases (28.9%) of gastric cancer cases. AKT and phosphorylated AKT were not correlated with any clinicopathological factor. We found that the gastric cancer patients who had higher AKT phosphorylation (activated AKT) seemed to have LOH of PTEN (p 5 0.0008). When the chemotherapeutic sensibilities of these patients were studied in an MTT assay, it was found that the activated AKT was associated with increased resistance to multiple chemotherapeutic agents (5-fluorouracil, adriamycin, mitomycin C and cis-platinum). The results of our study indicate that AKT activation and LOH of PTEN plays an important role in conferring a broad-spectrum chemoresistance in gastric cancer patients. It also indicates that AKT may therefore be a novel molecular target for therapies or chemosensitivity tests that improve the outcomes of gastric cancer patients. ' 2005 Wiley-Liss, Inc.

No abstract